ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy

BACKGROUND: Polymorphisms in the excision repair cross-complimentary group 1 (ERCC1) gene have been involved in the prognosis of various cancers. In the present study, we evaluated the prognostic role of the two most common ERCC1 polymorphisms in patients with T4 breast cancer receiving platinum-bas...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Palomba, Grazia, Atzori, Francesco, Budroni, Mario, Ombra, MariaNeve, Cossu, Antonio, Sini, MariaCristina, Pusceddu, Valeria, Massidda, Bruno, Frau, Barbara, Notari, Francesca, Ionta, MariaTeresa, Palmieri, Giuseppe
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2014
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4177579/
https://ncbi.nlm.nih.gov/pubmed/25253066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-014-0272-4
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы